公司簡介

Mononuclear Therapeutics Limited

Mononuclear Therapeutics (MonoTx) engages in developing umbilical cord blood mononuclear cellular therapies for disease treatment and life-saving. MonoTx collects, processes and banks umbilical cord blood in compliance with the international standards for related and unrelated malignant hematologic disorders. MonoTx’s cord blood bank is AABB accredited and FDA registered. MonoTx is developing cord blood based cellular therapies for safe and effective treatment of spinal cord injury, stroke, macular degeneration, and neonatal hypoxic-ischemia encephalopathy.

Unit 211, Building 16W No. 16 Science Park West Avenue Hong Kong Science Park, Shatin Hong Kong
+852 39971726
Mononuclear Therapeutics Limited /

以上資料僅供參考。有關園區公司的最新資訊,請以其官方公布的訊息為準。

聯絡我們

如有查詢或對香港科技園的服務與援助計劃有疑問,請在下方空白處填寫您的電郵地址和詢問內容。